Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1727 (LINC01727) is a long non-coding RNA gene identified as a lincRNA located on chromosome 20 (chr20:21570138-21578028, hg38)[1][3][5]. It consists of at least two exons and displays no protein-coding potential based on multiple predictive algorithms and experimental datasets[1]. The RNA is classified as intergenic, meaning it is transcribed from genomic regions that do not overlap coding genes. LINC01727 is also referred to as IRENA (IFN-responsive nuclear NF-κB activator), but there are currently no linked scientific publications providing experimental evidence for its precise biological function, molecular mechanism, or involvement in human disease. Its nomenclature suggests presumed association with interferon response and activation of the NF-κB pathway, but direct functional data are lacking as of the latest database updates[1][3][5]. No interacting drugs, biomarker status, or safety/therapeutic considerations have been described in available references[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1727 (LINC01727).